Clonal growth and tumorigenicity of HCC cells harboring the 11q13.3 amplicon were selectively suppressed by an anti-FGF19 antibody as well as by RNAi-mediated knockdown of FGF19 or CCND1 [42]. The gene discussed is FGF19; the disease is hepatocellular carcinoma.